{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:25:25Z","timestamp":1785551125503,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015502","name":"Dialysis Clinics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015502","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.amjms.2022.08.003","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T18:45:21Z","timestamp":1661625921000},"page":"329-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of psoriasis with myocardial infarction in end-stage renal disease patients"],"prefix":"10.1016","volume":"365","author":[{"given":"Naomi","family":"Siddiquee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Waller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeem","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Budder","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Padala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lufei","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mufaddal","family":"Kheda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy B.","family":"Bollag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.amjms.2022.08.003_bib0001","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jaad.2013.11.013","article-title":"Psoriasis prevalence among adults in the United States","volume":"70","author":"Rachakonda","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.amjms.2022.08.003_bib0002","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/abd1806-4841.20153038","article-title":"Psoriasis: classical and emerging comorbidities","volume":"90","author":"Oliveira Mde","year":"2015","journal-title":"An Bras Dermatol"},{"issue":"10","key":"10.1016\/j.amjms.2022.08.003_bib0003","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3390\/ijms18102211","article-title":"Psoriasis and cardiovascular comorbidities: focusing on severe vascular events, cardiovascular risk factors and implications for treatment","volume":"18","author":"Hu","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.amjms.2022.08.003_bib0004","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/joim.13311","article-title":"Prevalence and severity of coronary artery disease linked to prognosis in psoriasis and psoriatic arthritis patients: a multi-centre cohort study","volume":"290","author":"Tinggaard","year":"2021","journal-title":"J Intern Med"},{"issue":"11","key":"10.1016\/j.amjms.2022.08.003_bib0005","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/jamadermatol.2016.2907","article-title":"Comparison of coronary artery calcium scores between patients with psoriasis and type 2 diabetes","volume":"152","author":"Mansouri","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.amjms.2022.08.003_bib0006","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/bjd.12002","article-title":"Association of psoriasis with stroke and myocardial infarction: meta-analysis of cohort studies","volume":"167","author":"Xu","year":"2012","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.amjms.2022.08.003_bib0007","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s11255-018-1868-z","article-title":"Psoriasis and risk of incident chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis","volume":"50","author":"Ungprasert","year":"2018","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"10.1016\/j.amjms.2022.08.003_bib0008","doi-asserted-by":"crossref","first-page":"16581","DOI":"10.1038\/s41598-019-53017-4","article-title":"Risk of end-stage renal disease in psoriatic patients: real-world data from a nationwide population-based cohort study","volume":"9","author":"Lee","year":"2019","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.amjms.2022.08.003_bib0009","doi-asserted-by":"crossref","first-page":"775. e1-6","DOI":"10.1016\/j.amjmed.2011.03.028","article-title":"Attributable risk estimate of severe psoriasis on major cardiovascular events","volume":"124","author":"Mehta","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.amjms.2022.08.003_bib0010","first-page":"119","article-title":"Psoriasis and comorbidities: links and risks","volume":"7","author":"Ni","year":"2014","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.amjms.2022.08.003_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjms.2021.03.009","article-title":"Treatment of psoriasis in end-stage renal disease patients is associated with decreased mortality: a retrospective cohort study","author":"Schwade","year":"2021","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.amjms.2022.08.003_bib0012","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s13555-016-0153-2","article-title":"Under-treatment of patients with moderate to severe psoriasis in the united states: analysis of medication usage with health plan data","volume":"7","author":"Armstrong","year":"2017","journal-title":"Dermatol Ther"},{"issue":"6","key":"10.1016\/j.amjms.2022.08.003_bib0013","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2007.06.042","article-title":"Are patients with psoriasis undertreated? Results of national psoriasis foundation survey","volume":"57","author":"Horn","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjms.2022.08.003_bib0014","unstructured":"United States Renal Data System. 2019 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2019."},{"issue":"5","key":"10.1016\/j.amjms.2022.08.003_bib0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"10","key":"10.1016\/j.amjms.2022.08.003_bib0016","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamadermatol.2013.5015","article-title":"Psoriasis severity and the prevalence of major medical comorbidity: a population-based study","volume":"149","author":"Yeung","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.amjms.2022.08.003_bib0017","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.amjms.2022.08.003_bib0018","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7150\/ijms.7.284","article-title":"Pathogenic mechanisms shared between psoriasis and cardiovascular disease","volume":"7","author":"Ghazizadeh","year":"2010","journal-title":"Int J Med Sci"},{"issue":"14","key":"10.1016\/j.amjms.2022.08.003_bib0019","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.amjms.2022.08.003_bib0020","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.amjms.2022.08.003_bib0021","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jaad.2010.01.050","article-title":"Increased risk of acute myocardial infarction in patients with psoriasis: a 5-year population-based study in Taiwan","volume":"64","author":"Lin","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjms.2022.08.003_bib0022","unstructured":"Catalogue of bias collaboration, Aronson JK, Bankhead C, Nunan D. Confounding. In Catalogue Of Biases. 2018. www.catalogueofbiases.org\/biases\/confounding."},{"issue":"1","key":"10.1016\/j.amjms.2022.08.003_bib0023","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0031-1298595","article-title":"Assessing bias: the importance of considering confounding","volume":"3","author":"Skelly","year":"2012","journal-title":"Evid Based Spine Care J"},{"issue":"7","key":"10.1016\/j.amjms.2022.08.003_bib0024","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ejhf.113","article-title":"Psoriasis and risk of heart failure: a nationwide cohort study","volume":"16","author":"Khalid","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.amjms.2022.08.003_bib0025","first-page":"264","article-title":"TNF-alpha and apoptosis: implications for the pathogenesis and treatment of psoriasis","volume":"1","author":"Victor","year":"2002","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.amjms.2022.08.003_bib0026","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13075-018-1669-x","article-title":"Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study","volume":"20","author":"Lee","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.amjms.2022.08.003_bib0027","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/annrheumdis-2016-209784","article-title":"Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis","volume":"76","author":"Low","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.amjms.2022.08.003_bib0028","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.autrev.2011.04.014","article-title":"Cardiovascular safety of anti-TNF-alpha therapies: facts and unsettled issues","volume":"10","author":"Cacciapaglia","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.amjms.2022.08.003_bib0029","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7812\/TPP\/13-092","article-title":"Relationship between tumor necrosis factor-alpha inhibitors and cardiovascular disease in psoriasis: a review","volume":"18","author":"Nguyen","year":"2014","journal-title":"Perm J"},{"issue":"12","key":"10.1016\/j.amjms.2022.08.003_bib0030","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","article-title":"New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality","volume":"57","author":"Sundararajan","year":"2004","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.amjms.2022.08.003_bib0031","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1475-6773.2007.00822.x","article-title":"Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database","volume":"43","author":"Quan","year":"2008","journal-title":"Health Serv Res"},{"issue":"8","key":"10.1016\/j.amjms.2022.08.003_bib0032","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/pds.3447","article-title":"Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009","volume":"22","author":"Asgari","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"10.1016\/j.amjms.2022.08.003_bib0033","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jamadermatol.2013.5264","article-title":"Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011","volume":"149","author":"Armstrong","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"11","key":"10.1016\/j.amjms.2022.08.003_bib0034","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.2215\/CJN.08170910","article-title":"CMS 2728: what good is it?","volume":"5","author":"Eggers","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 2","key":"10.1016\/j.amjms.2022.08.003_bib0035","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2133.2008.08779.x","article-title":"Long-term prognosis in patients with psoriasis","volume":"159","author":"Gulliver","year":"2008","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.amjms.2022.08.003_bib0036","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaad.2008.01.006","article-title":"National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening","volume":"58","author":"Kimball","year":"2008","journal-title":"J Am Acad Dermatol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922003445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922003445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:16:01Z","timestamp":1762082161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962922003445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0002962922003445"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2022.08.003","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of psoriasis with myocardial infarction in end-stage renal disease patients","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2022.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation.","name":"copyright","label":"Copyright"}]}}